Health Condition 1: null- Children with wheezing
Conditions
Interventions
Intervention1: Levosalbutamol: levosalbutamol 0.075 mg/kg/dose
administered at intervals of twenty minutes for the first hour and then 6hrly for the next 24 hrs.
Control Intervention1: salbutamol: sa
Sponsors
Bombay Hospital Trust
Eligibility
Inclusion criteria
Inclusion criteria: All children from one month to 18 years of age admitted to the pediatric ward with wheezing were included in the study.
Exclusion criteria
Exclusion criteria: Children admitted to the intensive care units, those with co-existing renal or cardiac abnormalities, known intolerance to the drugs or currently on medications known to lower serum potassium levels or cause tachycardia like oral beta 2 agonists and diuretics, were excluded from the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart rate was measured by examination of the pulse and by a pulse oximeter. Oxygen saturation was monitored using a portable hand held pulse oximeter with a pediatric probe. Serum potassium levels were analysed by biochemical methods and tremors as reported by the parent or confirmed on clinical examination.Timepoint: All outcomes were measured at baseline.end of 1 hour and at the end of 24 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NA | — |
Countries
India
Contacts
Public ContactSuba Sundaresan
Bombay Hospital Institute of Mdical sciences and research
Outcome results
None listed